- Home
- THRM vs SNDX Comparison
THRM vs SNDX Comparison
Compare THRM & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRM
- SNDX
- Stock Information
- Founded
- THRM 1991
- SNDX 2005
- Country
- THRM United States
- SNDX United States
- Employees
- THRM N/A
- SNDX N/A
- Industry
- THRM Auto Parts:O.E.M.
- SNDX Biotechnology: Pharmaceutical Preparations
- Sector
- THRM Consumer Discretionary
- SNDX Health Care
- Exchange
- THRM Nasdaq
- SNDX Nasdaq
- Market Cap
- THRM 1.2B
- SNDX 1.2B
- IPO Year
- THRM 1993
- SNDX 2016
- Fundamental
- Price
- THRM $33.08
- SNDX $16.38
- Analyst Decision
- THRM Buy
- SNDX Strong Buy
- Analyst Count
- THRM 3
- SNDX 10
- Target Price
- THRM $51.67
- SNDX $36.20
- AVG Volume (30 Days)
- THRM 262.6K
- SNDX 2.6M
- Earning Date
- THRM 02-19-2025
- SNDX 03-04-2025
- Dividend Yield
- THRM N/A
- SNDX N/A
- EPS Growth
- THRM 68.85
- SNDX N/A
- EPS
- THRM 2.06
- SNDX N/A
- Revenue
- THRM $1,456,124,000.00
- SNDX $16,000,000.00
- Revenue This Year
- THRM $7.75
- SNDX N/A
- Revenue Next Year
- THRM $6.05
- SNDX N/A
- P/E Ratio
- THRM $16.06
- SNDX N/A
- Revenue Growth
- THRM N/A
- SNDX N/A
- 52 Week Low
- THRM $30.25
- SNDX $12.06
- 52 Week High
- THRM $58.17
- SNDX $25.34
- Technical
- Relative Strength Index (RSI)
- THRM 27.10
- SNDX 68.27
- Support Level
- THRM $30.25
- SNDX $14.53
- Resistance Level
- THRM $36.60
- SNDX $15.40
- Average True Range (ATR)
- THRM 1.46
- SNDX 0.70
- MACD
- THRM -0.34
- SNDX 0.13
- Stochastic Oscillator
- THRM 34.72
- SNDX 82.93
About THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.